1. Home
  2. JAGX vs FBGL Comparison

JAGX vs FBGL Comparison

Compare JAGX & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$3.87

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

N/A

Current Price

$3.65

Market Cap

5.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
FBGL
Founded
2013
1996
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.3M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
JAGX
FBGL
Price
$3.87
$3.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 3.1M
929.2K
Earning Date
11-16-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 82.42
N/A
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
N/A
Revenue This Year
$77.78
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.20
$0.33
52 Week High
$41.53
$4.30

Technical Indicators

Market Signals
Indicator
JAGX
FBGL
Relative Strength Index (RSI) 49.80 81.09
Support Level $0.89 $0.51
Resistance Level $8.00 N/A
Average True Range (ATR) 4.48 0.20
MACD -0.30 0.40
Stochastic Oscillator 10.26 82.39

Price Performance

Historical Comparison
JAGX
FBGL

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

Share on Social Networks: